Background. Immunoglobulin A nephropathy (IgAN) is one of the most common types of glomerulonephritis throughout the world. It is considered to be a complex disease, to which both genetic and environmental factors contribute. Our previous study has shown a potential interaction of C1GALT1− 330G/T and IL5RA31 + 197A/G on the susceptibility of IgAN in Southern Han Chinese. However, the interaction of these gene polymorphisms and the clinical manifestation for IgAN has not been investigated. Objective. This study aims to investigate whether genetic variants influence the clinical manifestation for IgAN patients and to assess the relationship between the genotype and phenotype of IgAN. Methods. Thirty-one SNPs in 24 candidate genes were selected in this study, which were involved in the pathways implicated in the development or progression of IgAN. A total of 480 IgAN patients with integrated clinical data were investigated. Data were analyzed using logistic regression and multifactor dimensionality reduction (MDR). The genotype-phenotype association was studied by correlations of single-locus and multi-locus interaction models with the clinical data. Results. The ADD1 G460W-dominant model for the G allele was significantly associated with hypertension of IgAN patients (P = 0.001, Pc = 0.031 and OR = 1.37). The TGF-β1-509T/Cdominant model for the C allele was significantly associated with proteinuria (≥1.0 g/d) of IgAN patients (P = 0.001, Pc = 0.031 and OR = 1.49). The MDR analysis of multiple SNPs revealed that P-selectin-2441A/G and CD14-159C/T had combined effects on macroscopic hematuria, whereas TGF-β1 509T/ C, P-selectin-2441A/G and MCP-1 2518A/G had combined effects on the formation of crescents in IgAN patients.
I N T RO D U C T I O N
Immunoglobulin A nephropathy (IgAN) is one of the most prevalent forms of primary glomerulonephritis throughout the world and is a major cause of end-stage renal failure [1] . About 25 to 30% IgAN patients progress to require renal replacement therapy within 10 to 20 years after disease onset, which forms a considerable public health burden [2] . Given the high prevalence of IgAN worldwide, and the diversity of clinical and pathological characteristics, there has been great interest in identifying factors that can predict the outcome of IgAN. Many clinical and histological factors have been shown to be associated with the progression of the disease, including hypertension, severe proteinuria, renal insufficiency and severe histological change of the renal biopsy specimens [3] [4] [5] .
In the past two decades, associations between genetic polymorphisms and clinical manifestations (including blood pressure, proteinuria, renal function and histological change of the renal biopsy) were analyzed to investigate the role of these genetic polymorphisms in the risk of progressive renal dysfunction in IgAN patients. In our previous study, we investigated 31 SNPs of 24 candidate genes in 527 IgAN cases and 543 healthy controls, which are involved in pathways known or suspected to be implicated in the development and progression of IgAN. Results showed that a potential interaction of C1GALT1−330G/T and IL5RA31 + 197A/G influences the susceptibility of IgAN in Southern Han Chinese [6] . However, the effects of both single-locus and multi-locus interaction of these genetic variants on the clinical manifestations of IgAN was not be investigated.
To investigate whether these genetic polymorphisms are associated with different clinical characteristics of IgAN patients, we continued to focus on both the single-locus and multi-locus interaction of these 24 candidate genes on the clinical manifestations of IgAN in Southern Han Chinese population.
M AT E R I A L S A N D M E T H O D S

Study population
Patients were recruited from the Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China. All cases were histopathologically diagnosed by renal biopsy following the criteria of the World Health Organization. A total of 527 patients (age, 31.1 ± 10.8 years; sex, 235 males and 292 females) with IgAN were enrolled in this study. All the patients underwent detailed medical and biochemical examinations. Clinical data were collected from these patients at diagnosis, which included proteinuria, blood pressure, serum creatinine and the presence of renal dysfunction (defined according to the K/DOQI Clinical Practice Guidelines for chronic kidney disease as glomerular filtration rate (GFR) is ≤60 mL/min × 1.73 m .) The patients were divided into different subgroups for stratified analysis, based on blood pressure (according to the standard of hypertension of WHO-ISH in 1999), 24-h proteinuria (≥1.0 or <1.0 g/24 h), renal function (GFR ≤ 60 or >60 mL/min × 1.73 m 2 ), hematuria (macroscopic hematuria or microscopic hematuria) and crescent formation (yes or no). The study was approved by the Institutional Review Board at The First Affiliated Hospital of Sun Yat-sen University. Informed consent was obtained from all of the participants.
DNA extraction and genotyping
The methods for DNA extraction and genotyping are described in the previous study [6] .
Data analysis
Genotypes were tested for Hardy-Weinberg equilibrium (HWE) using the chi-square test. The allele and genotype frequencies in IgAN patients in different clinical subgroups were compared using the chi-square test. Each genotype was assessed by logistic regression analysis assuming additive, dominant and recessive models of inheritance. Corrected P-values (Pc) were calculated using the Bonferroni inequality method.
The gene-gene interactions were evaluated using the method of multifactor dimensionality reduction (MDR), as outlined by Moore [7] , which has been implemented in the open-source MDR software package, version 0.6.1, available at www.epistasis.org.
R E S U LT S
Clinical information of IgAN patients
A total of 480 of 527 patients had complete clinical data. The clinical characteristics of the 480 IgAN patients are summarized in Table 1 . There were no deviations from HWE for 31 genetic polymorphisms in the IgAN patients (P > 0.05).
Single-locus effect on the clinical manifestations of IgAN In the single-locus analysis, several genes had significant differences in the allele and genotype distributions in IgAN, including ADD1 (rs4961) with hypertension (P = 0.002, P = 0.004, respectively) (Supplementary Table S1), TNF-α (rs361525) with macroscopic hematuria (P = 0.019, P = 0.018, respectively) (Supplementary Table S2 ) in both allele and genotype distributions; C1GALT1 (rs1008898) with renal dysfunction (P = 0.016) (Supplementary Table S3 ) and TGF-β1 (rs1800469) with 24-h proteinuria (≥1.0 g/24 h) (P = 0.002) (Supplementary Table S4 ) in genotype distribution. There was no genetic polymorphism associated with crescent formation in IgAN patients (Supplementary Table S5 ). Logistic regression analysis indicated that the G allele at rs4961 of ADD1 was significantly associated with hypertension of IgAN patients under the dominant and additive models of inheritance; the difference remained statistically significant under the dominant model even after adjustment by the Bonferroni inequality method (P = 0.001, Pc = 0.031 and OR = 1.37) (Supplementary Table S1 ). The C allele at rs1800469 of TGF-β1 was significantly associated with 24-h proteinuria (≥1.0 g/24 h) of IgAN patients under the dominant model of inheritance (P = 0.001, pc = 0.031 and OR = 1.49) (Supplementary Table S4 ). Other alleles of candidate genes in different models of inheritance were not associated with clinical subgroups among IgAN patients.
Multi-locus interaction effect on the clinical manifestations of IgAN MDR analysis was performed to investigate potential SNP-SNP interactions contributing to clinical manifestations of IgAN. The result is described in Table 2 . Significant interaction was observed between P-selectin-2441A/G and CD14-159C/T, which had combined effects on macroscopic hematuria in IgAN patients (TA = 0.805; CVC = 6/10; P = 0.001). Figure 1 illustrated the interaction analysis by MDR program. In this model, the coexistence of P-selectin-GG and CD14-CC genotypes was associated with high risk of gross hematuria in IgAN patients. Also, TGF-β1-509T/C, P-selectin-2441A/G and MCP-1-2518A/G had combined effects on the formation of crescent in IgAN patients (TA = 0.719; CVC = 7/10; P = 0.001) ( Table 2) . Finally, the combination of MCP-1-AA, TGF-β1-CC and P-selectin-AA genotypes was associated with susceptibility to glomerular crescent formation in IgAN patients ( Figure 2 ). No combined effects of any of these SNPs were detected on blood pressure, proteinuria and renal function in our study.
D I S C U S S I O N
Our study was performed with the aim to investigate the genetic single-locus and multi-locus interaction effects on the clinical manifestations of IgAN patients in Southern Han Chinese population. A total of 480 IgAN patients with integrated clinical data were analyzed in the study. We found that ADD1 (rs4961) was significantly associated with hypertension in the IgAN patients. This finding is consistent with that of the previous study, where the interaction between ACE and ADD1 polymorphisms in IgAN patients was found to influence not only blood pressure regulation but also the progression of renal dysfunction [8] . Adducins (ADDs) are a family of cytoskeleton proteins encoded by three genes (alpha, beta and gamma), which are heterodimeric proteins regulating actin polymerization and bundling, as well as basic cellular functions involving the actin cytoskeleton [9, 10] . In human α-adducin (ADD1), substitution of glycine by tryptophan at residue 460 (G460W) is implicated in the pathogenesis of salt-sensitive and low-renin hypertension, as well as enhancing tubular sodium re-absorption in the kidney [11, 12] . Our study confirmed the previous findings, supporting the association of ADD1 polymorphisms with hypertension in IgAN patients.
Another susceptibility gene is TGF-β1, where the C allele of TGF-β1 (rs1800469) was significantly associated with proteinuria (≥1.0 g/24 h) under the dominant model of inheritance in IgAN patients. Transforming growth factor-beta1 (TGF-β1) is a multifunctional cytokine, which regulates proliferation and differentiation of a variety of cell types, and plays a central role in the development and progression of renal injury in humans [13] . Our result is consistent with previous studies, where the incidence of proteinuria of 1.0 g/day or more was found significantly higher in patients with CC genotype of TGF-β1 than in those with other genotypes in Japanese [14] .
We confirmed the association of these two genes with the clinical manifestations in the single-gene study. However, we could not replicate the association of other candidate genes, although most of the candidate genes selected in our study had been shown to be associated with the different clinical manifestations of IgAN in previous studies. Furthermore, the results of these previous reports remain controversial. The lack of concordance across many of these studies reflected both the small sample sizes and the methodological limitations of using SNPs of single candidate genes in studying complex disease. It has been widely recognized that IgAN is a complex trait, where the simultaneous evaluation of several polymorphisms in separate genes on the complex disease may be a way forward for genetic studies [15] . Our previous study had shown a potential interaction of C1GALT1−330G/T and IL5RA 31 + 197A/G on the susceptibility to IgAN in Southern Han Chinese [6] . Thus, the potential SNP-SNP interactions contributing to clinical manifestations of IgAN should be further investigated. The MDR method was used to analyze the SNP-SNP interactions with clinical manifestations of IgAN. MDR analysis selected TGF-β1-509T/C, P-selectin-2441A/G and MCP-1-2518A/G as the best predictors of crescent formation in IgAN patients, which had more biological plausibility of crescent formation in IgAN patients from previous studies. Expression of TGF-β1 has mainly been reported to be associated with extracellular matrix expansion and interstitial fibrosis [13] . Selectin genes are cell-cell adhesion molecules involved in leukocyteendothelial cell interactions. P-selectin is predominantly expressed in the extra glomerular vascular endothelium in activated endothelial cells and platelets [16, 17] . Monocyte chemoattractant protein-1 (MCP-1) is a CC chemokine that attracts and activates monocytes and T-cells in acute inflammatory conditions [18] . In crescentic glomerulonephritis, MCP-1 is over-expressed within the glomeruli, and MCP-1 blockade has renal protective effects [19] . It is possible that each of the three genes, through their own biological pathway, had combined effects on the crescent formation in IgAN patients.
As for the macroscopic hematuria in IgAN patients, MDR analysis selected P-selectin-2441A/G and CD14-159C/T as the best predictors. One Chinese study found that altered expression of P-selectin (CD62P) in peripheral blood significantly correlated not only with hematuria and proteinuria, but also with the degree of tubulointerstitial injury in IgAN children [20] . CD14 encodes as a cell surface antigen expressed in monocytes/macrophages, which cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide. Previous studies had showed that CD14/-159 polymorphism may be an important marker for the progression of IgAN and may modulate the level of the inflammatory responses [21] . We speculate, based on our results, that the two genes had combined effects on the susceptibility to macroscopic hematuria in IgAN patients. The possible mechanism underlying this needs to be further explored.
In the analysis of gene-gene interactions, we did not find that the ADD1 (rs4961) and TGF-β1 (rs1800469) polymorphism had interactive effects with other genes on the risk of hypertension or proteinuria (≥1.0 g/24 h) in IgAN patients.
The effect of interactions between P-selectin-2441A/G and CD14-159C/T on the susceptibility of IgAN with macroscopic hematuria. Each multi-locus genotype combination is considered high risk when the ratio of macroscopic hematuria-to-microscopic hematuria exceeds 1.0; otherwise, the cell is classified as low risk. High-risk combinations are depicted as darkly shaded cells, low-risk combinations as lightly shaded cells. For each cell, the left bar indicates the macroscopic hematuria; the right bar indicates the microscopic hematuria.
The effect of interactions between TGF-β1 509T/C, P-selectin-2441A/G and MCP-1 2518A/G on the susceptibility of IgAN with glomerular crescent. Each multi-locus genotype combination is considered high risk when the ratio of crescent formation to no crescent formation exceeds 1.0; otherwise, the cell is classified as low risk. High-risk combinations are depicted as darkly shaded cells, low-risk combinations as lightly shaded cells. For each cell, the left bar indicates the crescent formation; the right bar indicates no crescent formation.
Thus, ADD1 and TGF-β1 polymorphism may have independent main effects on risk of hypertension or proteinuria (≥1.0 g/24 h) in IgAN patients.
To our knowledge, this was the first study to investigate the effects of gene-gene interaction on the clinical manifestations within a relatively large number of candidate genes (>20) of IgAN, following up on the in-depth work of our previous study [6] . We have found several genes related to the clinical manifestation, including the incidence of hypertension, proteinuria, hematuria and crescent formation. However, we recognize that our study is a cross-sectional retrospective study, where the clinical information was obtained at the time the IgAN patients were diagnosed by the renal biopsy. To confirm our result, a long-term prospective study will be needed to assess the prognostic significance of these genetic polymorphisms of IgAN.
Another limitation of our work was that our conclusions are based on results of statistical analyses, which can only indicate the susceptibility genes most likely to be related to the clinical manifestation of IgAN. To confirm whether these were the causal genes and to understand the biological significance of our findings, further functional studies will be needed, both in vitro and in vivo studies. Also, our study was performed in the Han Chinese population. Given that there are ethnic and geographical variations in the prevalence of IgAN patients and the clinical manifestations, validation of our result in another separate population will be needed.
In summary, our study investigated the effect of gene-gene interactions within 24 genes on the clinical manifestations of IgAN and found several susceptibility variants associated with a number of clinical and pathological features. Further work will be needed to confirm these findings. Furthermore, as several genome-wide association studies of IgAN have emerged [22] [23] [24] , the gene-gene interaction analysis will eventually have to be performed on the genome-wide level (with the appropriate adjustments for multiple testing) to identify additional novel associations.
CO N C L U S I O N S
In a relatively large group of IgAN patients, we demonstrated that the ADD1 G460W (rs4961) and TGF-β1-509T/C (rs1800469) polymorphisms are associated with hypertension and proteinuria (≥1.0 g/24 h) in these patients, respectively. A combination of the TGF-β1-509T/C, P-selectin-2441A/G and MCP-1-2518A/G genotypes had effects on the glomerular crescent formation of IgAN, whereas a combination of Pselectin-2441A/G and CD14-159C/T had effects on macroscopic hematuria of IgAN. These results indicated that some of the clinical presentations in IgAN patients may be associated with both single gene effects and polygenic factors. As the results presented are based on statistical interaction analyses, further functional study will be needed. Also, validation in other populations will be needed to confirm our result. Furthermore, a long-term prospective study will be performed to establish the prognostic significance of these genetic polymorphisms.
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